Veracyte, Inc.

NasdaqGM:VCYT Stock Report

Market Cap: US$2.6b

Veracyte Management

Management criteria checks 3/4

Veracyte's CEO is Marc Stapley, appointed in Jun 2021, has a tenure of 3.25 years. total yearly compensation is $7.18M, comprised of 9% salary and 91% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth $4.18M. The average tenure of the management team and the board of directors is 2.6 years and 3.5 years respectively.

Key information

Marc Stapley

Chief executive officer

US$7.2m

Total compensation

CEO salary percentage9.0%
CEO tenure3.3yrs
CEO ownership0.2%
Management average tenure2.6yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 42%

Aug 18
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 42%

Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Aug 09
Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 76% Above Its Share Price

Jul 02
Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 76% Above Its Share Price

Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking

Jun 06
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking

Veracyte, Inc. (NASDAQ:VCYT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 09
Veracyte, Inc. (NASDAQ:VCYT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Lacklustre Performance Is Driving Veracyte, Inc.'s (NASDAQ:VCYT) Low P/S

Apr 18
Lacklustre Performance Is Driving Veracyte, Inc.'s (NASDAQ:VCYT) Low P/S

A Look At The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

Mar 18
A Look At The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

Veracyte Percepta Genomic Sequencing Classifier demonstrates accuracy in lung cancer risk

Jul 13

Veracyte: Not A Healthy Diagnosis

May 12

CEO Compensation Analysis

How has Marc Stapley's remuneration changed compared to Veracyte's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$54m

Mar 31 2024n/an/a

-US$68m

Dec 31 2023US$7mUS$650k

-US$74m

Sep 30 2023n/an/a

-US$50m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$5mUS$625k

-US$37m

Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$48m

Dec 31 2021US$6mUS$350k

-US$76m

Compensation vs Market: Marc's total compensation ($USD7.18M) is about average for companies of similar size in the US market ($USD6.73M).

Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.

CEO

Marc Stapley (54 yo)

3.3yrs

Tenure

US$7,184,634

Compensation

Mr. Marc A. Stapley serves as Chief Executive Officer at Veracyte, Inc. since June 1, 2021 and serves as its Director since June 08, 2021. He served as the Chief Executive Officer of Helix OpCo, LLC from A...

Leadership Team

NamePositionTenureCompensationOwnership
Marc Stapley
CEO & Director3.3yrsUS$7.18m0.16%
$ 4.2m
Rebecca Chambers
Executive VP & CFO3.2yrsUS$2.78m0.047%
$ 1.2m
Phillip Febbo
Chief Scientific & Medical Officerless than a yearUS$4.20mno data
Annie McGuire
Executive VP2.6yrsUS$2.48m0.022%
$ 564.2k
John Leite
Chief Commercial Officer for CLIA Business2yrsUS$2.77m0.0047%
$ 120.5k
Jonathan Wygant
VP & Chief Accounting Officer2.6yrsno data0.014%
$ 352.1k
Steven French
Senior VP & Chief Information Officer2.7yrsno datano data
Karen Possemato
Senior Vice President of Corporate Marketingless than a yearno datano data
Robert Brainin
Executive VP & Chief Business Officer3.2yrsno datano data
Corinne Danan
Senior Vice President1.4yrsno datano data
Beverly Alley
VP & Corporate Controller3.7yrsUS$1.29mno data
Shayla Gorman
Director of Investor Relationsno datano datano data

2.6yrs

Average Tenure

52.5yo

Average Age

Experienced Management: VCYT's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Marc Stapley
CEO & Director3.3yrsUS$7.18m0.16%
$ 4.2m
Karin Eastham
Independent Director11.8yrsUS$314.98k0.028%
$ 728.9k
Evan Jones
Independent Director16.6yrsUS$314.98k0.030%
$ 766.3k
Robert Epstein
Independent Chair9.7yrsUS$337.98k0.043%
$ 1.1m
Jens Holstein
Independent Director4.1yrsUS$327.47k0.021%
$ 549.8k
David Shafer
Directorno datano datano data
Edison Liu
Member of Scientific Advisory Boardno datano datano data
Muna Bhanji
Independent Director3.5yrsUS$299.98k0.030%
$ 771.9k
Thomas Miller
Directorno datano datano data
Eliav Barr
Independent Director2.1yrsUS$294.98k0.022%
$ 555.7k

3.5yrs

Average Tenure

64yo

Average Age

Experienced Board: VCYT's board of directors are considered experienced (3.5 years average tenure).